Also UAE for the riders they have are not putting in too many great performances on a broad level at times. Last years Tour was the first with something like a consistently strong climbing support for Pogacar. Visma or formely Ineos/Sky seem way more streamlined and dominant in what they focus on. Or put differently - if Pogacar was only a result of an expensive doping program that only UAE can afford, they would certainly want a Pogacar #2 and a Pogacar #3, and better support for their Pogacars and so on, no? MSR for example was a huge fail on teamlevel again.Pogacar’s winning record stretches way back before he joined UAE. eg 2018 Tour de l‘Avenir.
That said, since I am convinced doping is still a big part, and there is not only a difference in access but also response - it will never be a level-playing field.
On the other hand, one can also ask, to make it more philosophical, if winning the genetical lottery in terms of physical capacity is any more or any less pure luck than being a good responder to certain substances. Both cases are exogenous factors beyond the influence of oneself.
The most unfair thing is obviously the Armstrong type of case. Where one rider is protected by authorities and others are even specifically targeted if they come close to said rider. But I hope thats not the case this time.
Last edited: